Therapeutic Biologicals: Navigating Challenges and Opportunities

Therapeutic biologicals – including monoclonal antibodies, recombinant proteins, biosimilars, and cell/gene therapies—represent the future of targeted healthcare. As the global pharmaceutical landscape shifts, India is well-positioned to play a pivotal role. But realizing this potential requires addressing key hurdles while leveraging strategic advantages. Manufacturing Complexity & Quality Assurance: Biological products are inherently complex, derived from […]